Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Enhancement of Dissolution Rate and Formulation Development of Efavirenz Capsule Employing Solid Dispersion Method


Affiliations
1 Dept. of Pharmaceutical Technology, Bharati Vidyapeeth College of Pharmacy, Kolhapur-416013, MS, India
     

   Subscribe/Renew Journal


The research work was undertaken to improve dissolution rate of efavirenz (EFA). It has low aqueous solubility and low intrinsic dissolution rate. The solid dispersions were prepared by fusion method using 1:4(70%),1:4(80%), 1:8(70%) and 1:8(80%) ratio of EFA to the mixture of polyethylene glycol 400 (PEG) and polysorbate 80 (PS).The solid dispersions were characterized by differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD). Dispersions were evaluated to determine drug content, practical yield and invitro drug release. The DSC thermogram of solid dispersion showed complete amorphization of drug. FTIR study revealed absence of any chemical interaction between EFA and excipients solid dispersion. Solubility of EFA in solid dispersion was increased in distilled water. The drug content was found to be high. The invitro dissolution studies showed marked increase in the dissolution rate than pure drug. The dispersion with 1:8, 80% of EFA and PEG showed faster dissolution rate. The feasibility of packing solid dispersion into capsule was also investigated. Capsule employing pure EFA and EFA solid dispersion were evaluated. Capsules with solid dispersions showed rapid and higher dissolution rate. The study revealed enhancement of dissolution of the EFA by PEG when formulated as solid dispersion.

Keywords

Efavirenz, Solid Dispersion, Dissolution, Bioavailability
Subscription Login to verify subscription
User
Notifications
Font Size


  • Leuner C and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J.Pharm.50; 2000: 47–60.

  • Kalyanwat R and PatelS.Solid Dispersion: A Method for Enhancing Drug Dissolution. Int. J. Drug Forml. Res. 1(3); 2010: 1-14.

  • Chiou WL and Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60(9); 1971: 1281-1302.

  • Costa P and Lobo JMS. Modeling and comparison of dissolution profiles. Eur. J.Pharm. Sci.13; 2001: 123-133.

  • Dhirendra K, et al., Solid Dispersions: A Review. Pak. J. Pharm. Sci. 22(2); 2009: 234-246.

  • Vadnere MK. Coprecipitates and melts. In Encyclopedia of pharmaceutical technology edited by Swarbrick J and Boylan JC. New York, USA: Marcel Dekker, Inc. 2002; 2nd ed: pp. 641-647.

  • Betageri GV and Makarla KR. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int. J. Pharm.126; 1995:155-160.

  • Patro S and Choudhary AA. Effect of some hydrophilic polymers on dissolution rate of roxithromycin. Indian J. Pharm. Sci.67; 2005: 334-341.

  • Serajuddin ATM, et al., Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs. J. Pharm. Sci. 88; 1999: 1058–1066.

  • Akiladevi D, et al., Preparation and evaluation of paracetamol by solid dispersion technique. Int. J. Pharm. Pharm. Sci. 3(1); 2011: 188-191.

  • Averineni RK, et al., Enhanced dissolution and bioavailability of gliclazide using solid dispersion techniques. Int. J. Drug Deliv. 2; 2010: 49-57.

  • Zaki Aand Abdel-Raheem I. Solubility enhancement of meloxicam prepared via binary and ternary phases using spray congealing. Asian J. Pharm. Health Sci. 1(4); 2011: 196-203.

  • Timko RJ and Lordi NG. Thermal analysis studies of glass dispersion systems. Drug Dev. Ind. Pharm.10(3); 1984: 425-451.

  • Damian F, et al., Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. Int. J. Pharm. 244(1-2); 2002: 87-98.

  • Vippagunta SR, et al., Solid-state characterization of nifedipine solid dispersions. Int. J. Pharm. 236(1-2); 2002: 111-123.

  • Save T and Venkitachalam P. Studies on solid dispersions of nifedipine. Drug Dev. Ind. Pharm. 18(15); 1992: 1663-1679.

  • McGinity JW, Maincent P and Steinfink H. Crystallinity and dissolution rate of tolbutamide solid dispersions prepared by the melt method. J. Pharm. Sci. 73(10); 1984: 1441-1444.

  • Morris KR, Knipp GT and Serajuddin ATM. Structural properties of poly (ethylene glycol)- polysorbate 80 mixture, a solid dispersion vehicle. J. Pharm. Sci. 81; 1992: 1185-1188.

  • Serajuddin ATM, et al., Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly- water soluble drug from solid dispersions. J. Pharm. Sci.77; 1988: 414-417.

  • Appa Rao B. et al., Formulation and evaluation of aceclofenac solid dispersions for dissolution rate enhancement. Int. J. Pharm. Sci. Drug Res. 2(2); 2010: 146-150.

  • Hajare AA, More HN and D’souza JI. Design and Evaluation of sustained release tablets of Diltiazem Hydrochloride., Indian Drugs. 41(3); 2004: 176.

  • Patil PB, Hajare AA and Awale RP. Development and Evaluation of Mesalamine Tablet Formulation for Colon Delivery. Res. J. Pharm. and Tech. 4(11):Nov. 2011.


Abstract Views: 700

PDF Views: 0




  • Enhancement of Dissolution Rate and Formulation Development of Efavirenz Capsule Employing Solid Dispersion Method

Abstract Views: 700  |  PDF Views: 0

Authors

Ashok A. Hajare
Dept. of Pharmaceutical Technology, Bharati Vidyapeeth College of Pharmacy, Kolhapur-416013, MS, India
Udaykumar T. Kashid
Dept. of Pharmaceutical Technology, Bharati Vidyapeeth College of Pharmacy, Kolhapur-416013, MS, India
Pravin Walekar
Dept. of Pharmaceutical Technology, Bharati Vidyapeeth College of Pharmacy, Kolhapur-416013, MS, India
Pravin M. Hajare
Dept. of Pharmaceutical Technology, Bharati Vidyapeeth College of Pharmacy, Kolhapur-416013, MS, India

Abstract


The research work was undertaken to improve dissolution rate of efavirenz (EFA). It has low aqueous solubility and low intrinsic dissolution rate. The solid dispersions were prepared by fusion method using 1:4(70%),1:4(80%), 1:8(70%) and 1:8(80%) ratio of EFA to the mixture of polyethylene glycol 400 (PEG) and polysorbate 80 (PS).The solid dispersions were characterized by differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD). Dispersions were evaluated to determine drug content, practical yield and invitro drug release. The DSC thermogram of solid dispersion showed complete amorphization of drug. FTIR study revealed absence of any chemical interaction between EFA and excipients solid dispersion. Solubility of EFA in solid dispersion was increased in distilled water. The drug content was found to be high. The invitro dissolution studies showed marked increase in the dissolution rate than pure drug. The dispersion with 1:8, 80% of EFA and PEG showed faster dissolution rate. The feasibility of packing solid dispersion into capsule was also investigated. Capsule employing pure EFA and EFA solid dispersion were evaluated. Capsules with solid dispersions showed rapid and higher dissolution rate. The study revealed enhancement of dissolution of the EFA by PEG when formulated as solid dispersion.

Keywords


Efavirenz, Solid Dispersion, Dissolution, Bioavailability

References